CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 100.0%

Compliant submissions 2

Incompliant submissions 0

Total trials 2

My Organizations' Clinical Trials

Showing 725 of 2003 entries

View as:

Remotely Resolving Psychological Stress (Remote RePS)

Phase: N/A Priority: Normal

NCT ID: NCT03196999 Org: User:

Start: 11/30/17 End: 11/01/18 Due: 11/01/19

Neurocognitive Outcomes In Patients Treated With Radiotherapy For Five Or More Brain Metastases

Phase: N/A Priority: Normal

NCT ID: NCT01731704 Org: User:

Start: 12/31/12 End: 12/31/18 Due: 12/31/19

BIIB092 in Primary Tauopathies: CBS, nfvPPA, sMAPT, and TES

Phase: N/A Priority: Normal

NCT ID: NCT03658135 Org: User:

Start: 09/12/18 End: 12/13/19 Due: 12/13/20

Encorafenib, Binimetinib, and Nivolumab in Treating Microsatellite Stable BRAF V600E Metastatic Colorectal Cancer

Phase: N/A Priority: Normal

NCT ID: NCT04044430 Org: User:

Start: 08/31/20 End: 07/31/22 Due: 07/31/23

Bevacizumab Therapy for Brain Arteriovenous Malformation

Phase: N/A Priority: Normal

NCT ID: NCT02314377 Org: User:

Start: 06/30/16 End: 12/01/19 Due: 12/01/20

Prehab and Creatine/Whey Supplementation in Frailty Among Patients With Cirrhosis

Phase: N/A Priority: Normal

NCT ID: NCT07029243 Org: User:

Start: 10/31/25 End: 12/31/26 Due: 12/31/27

Caring for Providers to Improve Patient Experience Study Phase 2 in Migori County

Phase: N/A Priority: Normal

NCT ID: NCT05019131 Org: User:

Start: 08/16/21 End: 08/31/23 Due: 08/31/24

Community to Clinic Linkage Program at SFGH

Phase: N/A Priority: Normal

NCT ID: NCT01939704 Org: User:

Start: 10/31/13 End: 10/31/19 Due: 10/31/20

Commercial or Open Source Closed Loop Impact on Pregnancy Study

Phase: N/A Priority: Normal

NCT ID: NCT06654713 Org: User:

Start: 03/13/25 End: 12/31/29 Due: 12/31/30

Optimizing an Integrated Mind and Body Treatment for Insomnia: The SLEEPS Study 2

Phase: N/A Priority: Normal

NCT ID: NCT07036705 Org: User:

Start: 11/30/25 End: 07/31/27 Due: 07/31/28

The Brain Health Study: A Pragmatic, Patient-Centered Trial

Phase: N/A Priority: Normal

NCT ID: NCT05905796 Org: User:

Start: 12/07/22 End: 10/05/25 Due: 10/05/26

Adverse Outcomes Following Female Genital Fistula Repair

Phase: N/A Priority: Normal

NCT ID: NCT05437939 Org: User:

Start: 05/20/22 End: 07/31/26 Due: 07/31/27

Empowering Newcomer Voices: A Trauma-Informed, Gender-Responsive Group Intervention in Schools (VOCES-NUEVAS)

Phase: N/A Priority: Normal

NCT ID: NCT07041931 Org: User:

Start: 08/31/26 End: 12/31/26 Due: 12/31/27

Carfilzomib With Bendamustine and Rituximab in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma

Phase: N/A Priority: Normal

NCT ID: NCT02187133 Org: User:

Start: 05/05/15 End: 03/31/21 Due: 03/31/22

Association Between Drug Levels, Malaria, and Antimalarial Resistance in the Setting of Seasonal Malaria Chemoprevention

Phase: N/A Priority: Normal

NCT ID: NCT04969185 Org: User:

Start: 08/16/21 End: 05/23/23 Due: 05/23/24

Group Antenatal/Postnatal Care in Rwanda

Phase: N/A Priority: Normal

NCT ID: NCT03154177 Org: User:

Start: 05/15/17 End: 05/31/19 Due: 05/31/20

Tobacco Intervention in Buprenorphine Treatment

Phase: N/A Priority: Normal

NCT ID: NCT01350011 Org: User:

Start: 04/01/11 End: 12/01/16 Due: 12/01/17

Prevention of De Novo HCV With Antiviral HCV Therapy Post-Liver and Post-Kidney Transplant

Phase: N/A Priority: Normal

NCT ID: NCT03619837 Org: User:

Start: 07/15/18 End: 08/13/20 Due: 08/13/21

Role of Growth Hormone Antagonism in Modulating Insulin Sensitivity in Subjects With Pre-diabetes

Phase: N/A Priority: Normal

NCT ID: NCT02023918 Org: User:

Start: 01/31/14 End: 12/31/15 Due: 12/31/16

Educational Program to Improve Heart Failure Outcomes in Adults Living in Rural Areas

Phase: N/A Priority: Normal

NCT ID: NCT00415545 Org: User:

Start: 01/31/07 End: 01/31/13 Due: 01/31/14

Trial of pDNA CMV Vaccine (VCL-CT02) Followed by Towne CMV Vaccine (Towne) Challenge

Phase: N/A Priority: Normal

NCT ID: NCT00373412 Org: User:

Start: 10/31/06 End: - Due: -

Clinical Evaluation of Cardiac Output Estimation Based on Pulse Wave Transit Time

Phase: N/A Priority: Normal

NCT ID: NCT01877941 Org: User:

Start: 12/31/12 End: 12/31/13 Due: 12/31/14

Assessment of Clemastine Fumarate as a Remyelinating Agent in Multiple Sclerosis

Phase: N/A Priority: Normal

NCT ID: NCT02040298 Org: User:

Start: 01/31/14 End: 04/30/16 Due: 04/30/17

Depression Management Project

Phase: N/A Priority: Normal

NCT ID: NCT01150604 Org: User:

Start: 06/30/10 End: 06/30/13 Due: 06/30/14

Normative Radiographic Parameters and Growth Curve of Hips Less Than Six Weeks of Gestational Age Using Ultrasound

Phase: N/A Priority: Normal

NCT ID: NCT03109444 Org: User:

Start: 10/25/17 End: 10/01/24 Due: 10/01/25

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Remotely Resolving Psychological Stress (Remote RePS)	NCT03196999	University of California, San Francisco	user2@example.com	None	2017-11-30	2018-11-01	2019-11-01	-	-	2025-07-14
Neurocognitive Outcomes In Patients Treated With Radiotherapy For Five Or More Brain Metastases	NCT01731704	University of California, San Francisco	user2@example.com	None	2012-12-31	2018-12-31	2019-12-31	-	-	2025-07-14
BIIB092 in Primary Tauopathies: CBS, nfvPPA, sMAPT, and TES	NCT03658135	University of California, San Francisco	user2@example.com	None	2018-09-12	2019-12-13	2020-12-13	-	-	2025-07-14
Encorafenib, Binimetinib, and Nivolumab in Treating Microsatellite Stable BRAF V600E Metastatic Colorectal Cancer	NCT04044430	University of California, San Francisco	user2@example.com	None	2020-08-31	2022-07-31	2023-07-31	-	-	2025-07-14
Bevacizumab Therapy for Brain Arteriovenous Malformation	NCT02314377	University of California, San Francisco	user2@example.com	None	2016-06-30	2019-12-01	2020-12-01	-	-	2025-07-14
Prehab and Creatine/Whey Supplementation in Frailty Among Patients With Cirrhosis	NCT07029243	University of California, San Francisco	user2@example.com	None	2025-10-31	2026-12-31	2027-12-31	-	-	2025-07-14
Caring for Providers to Improve Patient Experience Study Phase 2 in Migori County	NCT05019131	University of California, San Francisco	user2@example.com	None	2021-08-16	2023-08-31	2024-08-31	-	-	2025-07-14
Community to Clinic Linkage Program at SFGH	NCT01939704	University of California, San Francisco	user2@example.com	None	2013-10-31	2019-10-31	2020-10-31	-	-	2025-07-14
Commercial or Open Source Closed Loop Impact on Pregnancy Study	NCT06654713	University of California, San Francisco	user2@example.com	None	2025-03-13	2029-12-31	2030-12-31	-	-	2025-07-14
Optimizing an Integrated Mind and Body Treatment for Insomnia: The SLEEPS Study 2	NCT07036705	University of California, San Francisco	user2@example.com	None	2025-11-30	2027-07-31	2028-07-31	-	-	2025-07-14
The Brain Health Study: A Pragmatic, Patient-Centered Trial	NCT05905796	University of California, San Francisco	user2@example.com	None	2022-12-07	2025-10-05	2026-10-05	-	-	2025-07-14
Adverse Outcomes Following Female Genital Fistula Repair	NCT05437939	University of California, San Francisco	user2@example.com	None	2022-05-20	2026-07-31	2027-07-31	-	-	2025-07-14
Empowering Newcomer Voices: A Trauma-Informed, Gender-Responsive Group Intervention in Schools (VOCES-NUEVAS)	NCT07041931	University of California, San Francisco	user2@example.com	None	2026-08-31	2026-12-31	2027-12-31	-	-	2025-07-14
Carfilzomib With Bendamustine and Rituximab in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma	NCT02187133	University of California, San Francisco	user2@example.com	None	2015-05-05	2021-03-31	2022-03-31	-	-	2025-07-14
Association Between Drug Levels, Malaria, and Antimalarial Resistance in the Setting of Seasonal Malaria Chemoprevention	NCT04969185	University of California, San Francisco	user2@example.com	None	2021-08-16	2023-05-23	2024-05-23	-	-	2025-07-14
Group Antenatal/Postnatal Care in Rwanda	NCT03154177	University of California, San Francisco	user2@example.com	None	2017-05-15	2019-05-31	2020-05-31	-	-	2025-07-14
Tobacco Intervention in Buprenorphine Treatment	NCT01350011	University of California, San Francisco	user2@example.com	None	2011-04-01	2016-12-01	2017-12-01	-	-	2025-07-14
Prevention of De Novo HCV With Antiviral HCV Therapy Post-Liver and Post-Kidney Transplant	NCT03619837	University of California, San Francisco	user2@example.com	None	2018-07-15	2020-08-13	2021-08-13	-	-	2025-07-14
Role of Growth Hormone Antagonism in Modulating Insulin Sensitivity in Subjects With Pre-diabetes	NCT02023918	University of California, San Francisco	user2@example.com	None	2014-01-31	2015-12-31	2016-12-31	-	-	2025-07-14
Educational Program to Improve Heart Failure Outcomes in Adults Living in Rural Areas	NCT00415545	University of California, San Francisco	user2@example.com	None	2007-01-31	2013-01-31	2014-01-31	-	-	2025-07-14
Trial of pDNA CMV Vaccine (VCL-CT02) Followed by Towne CMV Vaccine (Towne) Challenge	NCT00373412	University of California, San Francisco	user2@example.com	None	2006-10-31	-	-	-	-	2025-07-14
Clinical Evaluation of Cardiac Output Estimation Based on Pulse Wave Transit Time	NCT01877941	University of California, San Francisco	user2@example.com	None	2012-12-31	2013-12-31	2014-12-31	-	-	2025-07-14
Assessment of Clemastine Fumarate as a Remyelinating Agent in Multiple Sclerosis	NCT02040298	University of California, San Francisco	user2@example.com	None	2014-01-31	2016-04-30	2017-04-30	-	-	2025-07-14
Depression Management Project	NCT01150604	University of California, San Francisco	user2@example.com	None	2010-06-30	2013-06-30	2014-06-30	-	-	2025-07-14
Normative Radiographic Parameters and Growth Curve of Hips Less Than Six Weeks of Gestational Age Using Ultrasound	NCT03109444	University of California, San Francisco	user2@example.com	None	2017-10-25	2024-10-01	2025-10-01	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance